This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Stewart, T. L. Articles by Ralston, S. H. Search for Related Content PubMed PubMed Citation Articles by Stewart, T. L. Articles by Ralston, S. H. Related Collections Calcium and Bone Metabolism

Haplotypes Defined by Promoter and Intron 1 Polymorphisms of the COLIA1 Gene Regulate Bone Mineral Density in Women

Department of Medicine and Therapeutics (T.L.S., H.J., F.E.A.M., A.B., D.M.R., S.H.R.), University of Aberdeen Medical School, Aberdeen AB25 2ZD, United Kingdom; Rheumatic Diseases Unit (H.J., O.M.E.A., S.H.R.), School of Molecular and Clinical Medicine, University of Edinburgh, Edinburgh EH4 2XU, United Kingdom; and University of Barcelona (N.G.-G., D.G., S.B.), Barcelona, Spain

Address all correspondence and requests for reprints to: Professor Stuart H. Ralston, Rheumatic Diseases Unit, Western General Hospital, Edinburgh EH4 2XU, United Kingdom. E-mail: stuart.ralston{at}ed.ac.uk.

Context: The COLIA1 gene is a strong candidate for susceptibility to osteoporosis. The causal genetic variants are currently unclear, but the most likely are functional polymorphisms in the promoter and intron 1 of COLIA1.

Objective: The objective of the study was to determine whether promoter and intron 1 polymorphisms of COLIA1 or haplotypes defined by these polymorphisms regulate bone mineral density (BMD) in women.

Design: This was a population-based association study involving 3270 women from the United Kingdom who took part in a regional osteoporosis screening program.

Main Outcome Measures: BMD at the lumbar spine (LS-BMD) and femoral neck (FN-BMD) was measured on two occasions approximately 6 yr apart, in relation to polymorphisms and haplotypes defined by polymorphisms within the COLIA1 intron 1 (+1245G/T; rs1800012) and promoter (–1997G/T; rs1107946; –1663IndelT; rs2412298).

Results: The polymorphisms were in strong linkage disequilibrium, and three haplotypes accounted for more than 95% of alleles at the COLIA1 locus. The individual polymorphisms were associated with BMD, but the most consistent associations were with haplotypes defined by all three polymorphisms. Homozygote carriers of haplotype 2 (–1997G/–1663delT/+1245T) had reduced BMD at baseline (P = 0.007 for LS-BMD; P = 0.008 for FN-BMD), whereas homozygotes for haplotype 3 (–1997T/–1663insT/+1245G) had increased BMD (P = 0.007 for LS-BMD). Similar associations were observed at follow-up for haplotype 3, but the association with haplotype 2 was weaker due to increased uptake of hormone replacement therapy in homozygotes for this haplotype.

Conclusions: Two haplotypes defined by polymorphisms in the 5' flank of the COLIA1 regulate BMD in a bidirectional manner in women.

This article has been cited by other articles:

				A. L. Boskey Mineralization of Bones and Teeth Elements, December 1, 2007; 3(6): 385 - 391. [Abstract] [Full Text] [PDF]